Vitro Biopharma, Inc To Start Trading Tomorrow

Vitro Biopharma, Inc VTRO IPO will take place September, 13 on the NASDAQ exchange under the ticker VTRO.

The company is offering shares at an expected price between $5.00 and $6.00 per share with an insider lock-up period of 180 days ending on March 11, 2024.

See also: Benzinga IPO Calendar

About Vitro Biopharma, Inc

Vitro Biopharma, Inc is an innovative biotechnology company targeting autoimmune diseases and inflammatory disorders, with an ancillary focus in the research services and cosmeceutical fields. With respect to our regenerative medicine business

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.